Benznidazole was granted accelerated approval for the treatment of Chagas disease in children 2-12 years of age by the FDA on August 29, 2017. It is the first treatment made available in the United States for Chagas disease.
For use in the treatment of Chagas disease in children 2-12 years of age .
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.